Glutamic Acid Decarboxylase 65 Antibodies (GAD65)
Autoantibodies directed against the 65-kDa isoform of glutamic acid decarboxylase, the rate-limiting enzyme synthesizing GABA in beta cells.
Standard vs. Optimal Reference RangesIU/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<5.0 IU/mL
General reference distribution across unselected commercial populations.
<1.0 IU/mL (negative)
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Targeted by autoreactive T-cell and B-cell responses, mediating progressive cytotoxic destruction of insulin-producing beta cells.
Differential Diagnosis
Elevated Levels (GAD65 High)
- •Latent Autoimmune Diabetes in Adults (LADA)
- •Type 1 Diabetes Mellitus (>70% of new-onset cases)
- •Stiff-Person Syndrome (high titers >100 IU/mL)
Low Levels (GAD65 Low)
- •Type 2 Diabetes (non-autoimmune)
- •Healthy autoimmune homeostasis
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for GAD65
- Targeted organ system imaging or functional dynamic testing related to pancreatic islet autoimmunity
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Glutamic Acid Decarboxylase 65 Antibodies - The New England Journal of Medicine (2021). PMID: 33990124
- [2]GAD65 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Glutamic Acid Decarboxylase 65 Antibodies (GAD65) into overall healthspan optimization.